| Probiotics and Fermented Foods | Lifetime | 29 | CN 1 | 99.80 |
| Gut microbiota and health | Lifetime | 59 | CN 4 | 99.72 |
| Microbial Metabolites in Food Biotechnology | Lifetime | 109 | CN 7 | 99.22 |
| Diet and metabolism studies | Lifetime | 642 | CN 11 | 98.88 |
| Metabolomics and Mass Spectrometry Studies | Lifetime | 330 | CN 24 | 98.11 |
| Infant Nutrition and Health | Lifetime | 180 | CN 2 | 98.18 |
| Microbial Metabolic Engineering and Bioproduction | Lifetime | 392 | CN 51 | 98.37 |
| Clostridium difficile and Clostridium perfringens research | Lifetime | 231 | CN 8 | 98.11 |
| Gastrointestinal motility and disorders | Lifetime | 383 | CN 5 | 97.31 |
| Cancer, Lipids, and Metabolism | Lifetime | 874 | CN 37 | 97.00 |
| Protein Hydrolysis and Bioactive Peptides | Lifetime | 596 | CN 116 | 96.80 |
| Tryptophan and brain disorders | Lifetime | 791 | CN 23 | 96.57 |
| Lipid metabolism and biosynthesis | Lifetime | 877 | CN 41 | 93.55 |
| Hydrogen's biological and therapeutic effects | Lifetime | 602 | CN 179 | 77.57 |
| Therapeutic Uses of Natural Elements | Lifetime | 881 | CN 41 | 77.98 |
| Antioxidants, Aging, Portulaca oleracea | Lifetime | 459 | CN 194 | 48.66 |
| Gut microbiota and health | 2021-2025 | 1 | CN 1 | 99.97 |
| Probiotics and Fermented Foods | 2021-2025 | 1 | CN 1 | 99.96 |
| Diet and metabolism studies | 2021-2025 | 9 | CN 1 | 99.78 |
| Clostridium difficile and Clostridium perfringens research | 2021-2025 | 3 | CN 2 | 99.40 |
| Gastrointestinal motility and disorders | 2021-2025 | 8 | CN 1 | 99.21 |
| Tryptophan and brain disorders | 2021-2025 | 22 | CN 4 | 99.10 |
| Infant Nutrition and Health | 2021-2025 | 18 | CN 7 | 98.28 |
| Metabolomics and Mass Spectrometry Studies | 2021-2025 | 67 | CN 18 | 97.35 |
| Microbial Metabolites in Food Biotechnology | 2021-2025 | 34 | CN 27 | 98.56 |
| Helicobacter pylori-related gastroenterology studies | 2021-2025 | 51 | CN 10 | 97.94 |
| Microbial Metabolic Engineering and Bioproduction | 2021-2025 | 160 | CN 76 | 96.20 |
| Bacteriophages and microbial interactions | 2021-2025 | 330 | CN 91 | 92.90 |
| Biochemical Analysis and Sensing Techniques | 2021-2025 | 167 | CN 79 | 93.00 |
| Protein Hydrolysis and Bioactive Peptides | 2021-2025 | 270 | CN 155 | 94.54 |
| Cancer, Lipids, and Metabolism | 2021-2025 | 336 | CN 115 | 91.64 |
| Genomics and Phylogenetic Studies | 2021-2025 | 561 | CN 165 | 92.78 |
| Oral microbiology and periodontitis research | 2021-2025 | 388 | CN 70 | 93.32 |
| Inflammatory Bowel Disease | 2021-2025 | 512 | CN 37 | 94.46 |
| Infant Health and Development | 2021-2025 | 102 | CN 5 | 87.17 |
| Pharmacological Effects of Natural Compounds | 2021-2025 | 406 | CN 249 | 86.90 |
| Fatty Acid Research and Health | 2021-2025 | 215 | CN 47 | 87.84 |
| Lipid metabolism and biosynthesis | 2021-2025 | 208 | CN 86 | 84.49 |
| Bacterial biofilms and quorum sensing | 2021-2025 | 565 | CN 140 | 85.64 |
| Dermatology and Skin Diseases | 2021-2025 | 906 | CN 92 | 87.92 |
| Digestive system and related health | 2021-2025 | 170 | CN 51 | 82.56 |
| Ginseng Biological Effects and Applications | 2021-2025 | 352 | CN 291 | 81.32 |
| Enzyme Production and Characterization | 2021-2025 | 537 | CN 189 | 81.88 |
| Phytoestrogen effects and research | 2021-2025 | 173 | CN 64 | 79.74 |
| Nutrition, Genetics, and Disease | 2021-2025 | 482 | CN 46 | 76.77 |
| Genomics, phytochemicals, and oxidative stress | 2021-2025 | 504 | CN 168 | 77.99 |
| Alcohol Consumption and Health Effects | 2021-2025 | 763 | CN 91 | 79.02 |
| Trace Elements in Health | 2021-2025 | 758 | CN 292 | 76.05 |
| Antimicrobial Peptides and Activities | 2021-2025 | 998 | CN 397 | 77.50 |
| Pediatric health and respiratory diseases | 2021-2025 | 707 | CN 75 | 75.35 |
| Gout, Hyperuricemia, Uric Acid | 2021-2025 | 743 | CN 358 | 68.12 |
| Eicosanoids and Hypertension Pharmacology | 2021-2025 | 706 | CN 146 | 60.22 |
| Pomegranate: compositions and health benefits | 2021-2025 | 349 | CN 51 | 58.19 |
| Milk Quality and Mastitis in Dairy Cows | 2021-2025 | 977 | CN 151 | 57.47 |
| Ion Channels and Receptors | 2021-2025 | 946 | CN 177 | 51.81 |
| Polyamine Metabolism and Applications | 2021-2025 | 954 | CN 389 | 47.19 |